Cytotoxic Effects of Thiazolo[3,2-C]Pyrimidines Against Mcf-7 And Hepg2/C3a Carcinoma Cell Lines

Abstract

I n the present study, a series of thiazolo[3,2-c]pyrimidines (4,5) have been produced via simple and efficient synthetic method and their in vitro cytotoxicities have been performed on human breast (MCF-7) and hepatocellular (HEPG2/C3A) adenocarcinoma cell lines. The results of these in vitro tests revealed that at least five of thiazolo[3,2-c]pyrimidines exhibited strong cytotoxic effects at very low concentrations, which were very similar or lower than that of reference anticancer agent, 5-FU, against MCF-7 and HEPG2/C3A cancer cell lines.

Keywords

• Anticancer,breast cancer,Mannich cyclisation,thiazolopyrimidines

References

1. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, R. Langer, Nanocarriers as an emerging platform for cancer therapy, Nat. Nanotechnol., 2 (2007) 751-760.
2. F. Arcamone, Doxorubicin: anticancer antibiotics, (2012) Elsevier, New York, NY, USA.
3. A. Nagy, P. Armatis, A.V. Schally, High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin, Proceedings of the National Academy of Sciences, 93 (1996) 2464-2469.
4. G. Rodriguez-Berna, M.J.D. Cabañas, V. MangasSanjuán, M. Gonzalez-Alvarez, I. Gonzalez-Alvarez, I. Abasolo, S. Schwartz Jr, M. Bermejo, A. Corma, Semisynthesis, Cytotoxic Activity, and Oral Availability of New Lipophilic 9-Substituted Camptothecin Derivatives, ACS Med. Chem. Lett., 4 (2013) 651-655.
5. M.C. Wani, H.L. Taylor, M.E. Wall, P. Coggon, A.T. McPhail, Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia, J. Am. Chem. Soc., 93 (1971) 2325-2327.
6. P.B. Schiff, J. Fant, S.B. Horwitz, Promotion of microtubule assembly in vitro by taxol, Nature, 277 (1979) 665-667.
7. D.B. Longley, D.P. Harkin, P.G. Johnston, 5-fluorouracil: mechanisms of action and clinical strategies, Nature reviews. Cancer, 3 (2003) 330-338.
8. B. Shi, B. Yaremko, G. Hajian, G. Terracina, W.R. Bishop, M. Liu, L.L. Nielsen, The farnesyl protein transferase inhibitor SCH66336 synergizes with taxanes in vitro and enhances their antitumor activity in vivo, Cancer Chemoth. Pharm., 46 (2000) 387-393.

9. O. Cuvillier, V. Nava, S. Murthy, L. Edsall, T. Levade, S. Milstien, S. Spiegel, Sphingosine generation, cytochrome C release, and activation of caspase-7 in doxorubicin-induced apoptosis of MCF7 breast adenocarcinoma cells, Cell Death. Differ., 8 (2001) 162-171.
10. F.W. Symmans, Breast cancer response to paclitaxel in vivo, Drug Resist. Update, 4 (2001) 297-302.
11. J. Wichmann, G. Adam, S. Kolczewski, V. Mutel, T. Woltering, Structure-activity relationships of substituted 5H-thiazolo[3,2-a]pyrimidines as group 2 metabotropic glutamate receptor antagonists, Bioorg. Med. Chem. Lett., 9 (1999) 1573-157.
12. F.A. Al-Omary, G.S. Hassan, S.M. El-Messery, H.I. ElSubbagh, Substituted thiazoles V. Synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d] thiazolo[3,2-a] pyrimidine analogues, Eur. J. Med. Chem., 47 (2012) 65-72.
13. S. Fatima, A. Sharma, R. Saxena, R. Tripathi, S.K. Shukla, S.K. Pandey, R. Tripathi, R.P. Tripathi, One pot efficient diversity oriented synthesis of polyfunctional styryl thiazolopyrimidines and their bio-evaluation as antimalarial and anti-HIV agents, Eur. J. Med. Chem., 55 (2012) 195-204.
14. M. Yıldırım, D. Çelikel,Y. Dürüst, D.W. Knight, B.M. Kariuki, A rapid and efficient protocol for the synthesis of novel nitrothiazolo[3,2-c]pyrimidines via microwave-mediated Mannich cyclisation, Tetrahedron, 70 (2014) 2122-2128.
15. E. Flefel, M. Salama, M. El-Shahat, M. El-Hashash, A. El-Farargy, A novel synthesis of some new pyrimidine and thiazolopyrimidine derivatives for anticancer evaluation, Phosphorus Sulfur., 182 (2007) 1739-1756.
16. R. Lin, S.G. Johnson, P.J. Connolly, S.K. Wetter, E. Binnun, T.V. Hughes, W.V. Murray, N.B. Pandey, S.J. Moreno-Mazza, M. Adams, Synthesis and evaluation of 2,7-diamino-thiazolo[4,5-d]pyrimidine analogues as anti-tumor epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, Bioorg. Med. Chem. Lett., 19 (2009) 2333-2337.
17. B. Singh, S.K. Guru, S. Kour, S.K. Jain, R. Sharma, P.R. Sharma, S.K. Singh, S. Bhushan, S.B. Bharate, R.A. Vishwakarma, Synthesis, antiproliferative and apoptosis-inducing activity of thiazolo[5,4-d] pyrimidines, Eur. J. Med. Chem., 70 (2013) 864-874.
18. T.A.A. Yahya, J.H. Abdullah, M.A.H. Al-Ghorafi, S.H. Yassin, H.M. Almahbshi, Synthesis of some arylidene derivatives of thiazolopyrimidineas anticancer, Der Pharma Chemica, 7 (2015) 106-110.
19. N.A. Abdel-Hafez, S.F. Mohamed, F.A. El-Hag, U.W. Hawas, H.M. Awad, Synthesis and Cytotoxicity Evaluation of Some New Pyrimidinethione and Thiazolopyrimidine Derivatives Linked to N-Propylpiperidone, Der Pharma Chemica, 8 (2016) 57-66.
20. B. Kuppast, H. Fahmy, Thiazolo[4,5-d]pyrimidines as a privileged scaffold in drug discovery, Eur.J. Med. Chem., 113 (2016) 198-213.
21. S. Kolb, O. Mondésert, M.L. Goddard, D. Jullien, B.O. Villoutreix, B. Ducommun, C. Garbay, E. Braud, Development of novel thiazolopyrimidines as CDC25B phosphatase inhibitors, ChemMedChem, 4 (2009) 633-648.
22. A.A. Abu-Hashem, M.M. Youssef, H.A. Hussein, Synthesis, antioxidant, antituomer activities of some new thiazolopyrimidines, pyrrolothiazolopyrimidines and triazolo pyrrolothiazolopyrimidines derivatives, J.Chil. Chem. Soc., 58 (2011) 41-48.
23. M. Yıldırım, D. Çelikel, A rapid access to novel and diverse 3-oxothiazolo[3,2-c]pyrimidine-8- carboxylates using multicomponent Mannich cyclisation reactions, Mol. Divers., 19 (2015) 1-13.
24. M. Stojanović, R. Marković, E. Kleinpeter, M. BaranacStojanović, endo-Mode cyclizations of vinylogous N-acyliminium ions as a route to the synthesis of condensed thiazolidines, Tetrahedron, 67 (2011) 9541- 9554.
25. D. Çelikel, Synthesis of new thiazolopyrimidine, thiazolo(imidazolo) pyridinone derivatives via multicomponent reactions M.Sc. Master Thesis, (2015) Abant İzzet Baysal University, Bolu,Turkey.
26. F.P. Karakas, A.B. Yildirim, R. Bayram, M.Z. Yavuz, A. Gepdiremen, A.U. Turker, Antiproliferative activity of some medicinal plants on human breast and hepatocellular carcinoma cell lines and their phenolic contents, Trop. J. Pharm. Res., 14 (2015) 1787-1795.
27. M.M. Kamel, H.I. Ali, M.M. Anwar, N.A. Mohamed, A.M. Soliman, Synthesis, antitumor activity and molecular docking study of novel sulfonamideSchiff’s bases, thiazolidinones, benzothiazinones and their C-nucleoside derivatives, Eur. J. Med. Chem., 45 (2010) 572-580.
28. X. Liu, W. Wei, S. Huang, S-S. Lin, X. Zhang, C. Zhang, Y. Du, G. Ma, M. Li, S. Mann, Bio-inspired protein– gold nanoconstruct with core–void–shell structure: beyond a chemo drug carrier, J. Mater. Chem. B., 1 (2013) 3136-3143.
29. G.S. Hassan, Synthesis and antitumor activity of certain new thiazolo[2,3-b]quinazoline and thiazolo[3,2-a] pyrimidine analogs, Med. Chem. Res., 23 (2014) 388-401.
30. L. Shen, J. Hu, H. Wang, A. Wang, Y. Lai, Y. Kang, Synthesis and biological evaluation of novel uracil and 5-fluorouracil-1-yl acetic acid-colchicine conjugate, Chem. Res. Chinese. U., 31(2015) 367-371.
31. P.N. Le, N.H. Nguyen, C.K. Nguyen, N.Q. Tran, Smart dendrimer-based nanogel for enhancing 5-fluorouracil loading efficiency against MCF7 cancer cell growth, B. Mater. Sci., 39 (2016) 1493-1500.
32. J.M. Gichumbi, B. Omondi, G. Lazarus, M. Singh, N. Shaikh, H.Y. Chenia, H.B. Friedrich, Influence of Halogen Substitution in the Ligand Sphere on the Antitumor and Antibacterial Activity of Half sandwich Ruthenium (II) Complexes [RuX( 6 arene) (C5H4N2 CH=N Ar)]+, Z. Anorg. Allg. Chem., 643 (2017) 699-711.
33. I.M. Abbas, S.M. Gomha, M.M. Elaasser, B.K. Mabrouk, Synthesis and characterisation of some novel fused thiazolo[3,2-a]pyrimidinones and pyrimido[2,1-b][1,3] thiazinones, J. Chem. Res., 39 (2015) 719-723.
34. S. Awad, O. Fathalla, J. Wietrzyk, M. Milczarek, A. Soliman, M.S. Mohamed, Synthesis of new pyrimidine derivatives and their antiproliferative activity against selected human cancer cell lines, Res. Chem. Intermediat., 41 (2015) 1789-1801.
35. S.M. Rida, S.A. El-Hawash, H.T. Fahmy, A.A. Hazza, M.M. El-Meligy, Synthesis and in vitro evaluation of some novel benzofuran derivatives as potential antiHIV-1, anticancer, and antimicrobial agents, Arch. Pharm. Res., 29 (2006) 16-25.
36. M.M. Mohamed, A.K. Khalil, E.M. Abbass, A.M. ElNaggar, Design, Synthesis of New Pyrimidine Derivatives as Anticancer and Antimicrobial Agents, Synthetic Commun., 47 (2017) 1441-1457.